Pharma Equity Group A/S Cl A (PEG) — Net Asset Momentum
Pharma Equity Group A/S Cl A (PEG) recorded a net asset momentum of -47.9% as of September 2025, with net assets of Dkr25.47 Million DKK. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Pharma Equity Group A/S Cl A (PEG) liquidity interval to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Pharma Equity Group A/S Cl A Net Asset Momentum (2008–2025)
This chart tracks Pharma Equity Group A/S Cl A's year-over-year net asset growth across 18 annual reporting periods from 2008 to 2025. The most recent momentum reading is -47.9%, with net assets of Dkr25.47 Million DKK as of September 2025. Read PEG total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Pharma Equity Group A/S Cl A (2008–2025)
The table below shows the complete annual net asset history for Pharma Equity Group A/S Cl A from 2008 to 2025, covering 18 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PEG stock market capitalisation.
| Year | Net Assets (DKK) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Dkr25.47 Million | Dkr38.90 Million | Dkr13.43 Million | ▼ -47.9% |
| 2024 | Dkr48.88 Million | Dkr65.61 Million | Dkr16.73 Million | ▲ +92.9% |
| 2023 | Dkr25.33 Million | Dkr67.74 Million | Dkr42.40 Million | ▼ -45.0% |
| 2022 | Dkr46.05 Million | Dkr71.07 Million | Dkr25.03 Million | ▲ +8.2% |
| 2021 | Dkr42.57 Million | Dkr63.65 Million | Dkr21.08 Million | ▲ +24.2% |
| 2020 | Dkr34.28 Million | Dkr57.58 Million | Dkr23.30 Million | ▼ -49.0% |
| 2019 | Dkr67.16 Million | Dkr80.84 Million | Dkr13.68 Million | ▼ -13.4% |
| 2018 | Dkr77.57 Million | Dkr80.84 Million | Dkr3.27 Million | ▼ -8.8% |
| 2017 | Dkr85.09 Million | Dkr86.30 Million | Dkr1.21 Million | ▼ -12.1% |
| 2016 | Dkr96.78 Million | Dkr125.75 Million | Dkr28.98 Million | ▼ -2.8% |
| 2015 | Dkr99.53 Million | Dkr126.25 Million | Dkr26.72 Million | ▲ +1.6% |
| 2014 | Dkr97.95 Million | Dkr123.97 Million | Dkr26.02 Million | ▲ +192.9% |
| 2013 | Dkr-105.44 Million | Dkr251.24 Million | Dkr356.68 Million | ▼ -389.8% |
| 2012 | Dkr36.39 Million | Dkr503.85 Million | Dkr467.46 Million | ▼ -54.3% |
| 2011 | Dkr79.67 Million | Dkr507.76 Million | Dkr428.10 Million | ▲ +50.1% |
| 2010 | Dkr53.06 Million | Dkr497.26 Million | Dkr444.20 Million | ▼ -0.8% |
| 2009 | Dkr53.47 Million | Dkr75.70 Million | Dkr22.24 Million | ▼ -4.9% |
| 2008 | Dkr56.25 Million | Dkr261.67 Million | Dkr205.42 Million | — |